无码中文字幕一Av王,91亚洲精品无码,日韩人妻有码精品专区,911亚洲精选国产青草衣衣衣

US EUROPE AFRICA ASIA 中文
Business / Companies

ChemChina 'mulling $10b share offering'

(China Daily) Updated: 2016-07-14 09:08

Sale of stock in a unit, combined with other moves, to fund Syngenta buy

China National Chemical Corp is planning to sell $10 billion worth of preference shares in one of its units, to help fund its record $43 billion acquisition of the world's biggest agrochemicals company Syngenta AG, according to sources who did not want to be identified.

Under the proposal, half of the preferred shares on sale would be convertible, according to sources. ChemChina also reportedly plans to raise another $15 billion in cash, bringing the total equity contribution to $25 billion, and borrow the rest it needs via a loan package.

Representatives at ChemChina did not immediately respond to calls and e-mails seeking comment.

Shares of Swiss group Syngenta closed 0.2 percent higher at 373.10 Swiss francs ($378) in Zurich on Tuesday, giving the company a market value of 34.5 billion francs.

The fundraising would put State-owned ChemChina a step closer to completing the country's biggest-ever acquisition outside its borders and help the government secure technology that could help feed the world's most-populous nation.

Still, hurdles remain as the deal is still subject to regulatory approvals in the United States during an election year.

The shares are poised to be sold to government-linked entities, according to two separate people familiar with the matter, who declined to name the buyers.

On the debt portion of the fundraising, ChemChina's lenders are preparing to line up $12.7 billion in bank financing in addition to a $20 billion loan in March, according to the sources.

Syngenta has said it expects the deal, which is being reviewed by the Committee on Foreign Investment in the US, will be completed by the end of 2016.

CFIUS can recommend to US President Barack Obama that transactions be blocked if they are deemed to pose a risk to national security.

Bloomberg

Hot Topics

Editor's Picks
...